L3VLUP
ProSign in

TEVA in the 13F filings

Teva Pharmaceutical Inds LTD · CUSIP 881624209

Sector · Pharmaceuticals and biotechnologyTheme · Healthcare: biopharma and medtech· L3VLUP-definedTheme · Pharmaceutical preparations
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023
Quarter end
30 Sep 2025
the date the book describes
Filed
17 Feb 2026
latest of these filings; the earliest 12 Nov 2025
Managers listing it
14
at least, of 95 tracked, among listed positions
Comparable managers
95
filed both Q2 2025 and Q3 2025; 7 listed it in both
Shares listed
47,725,422
combined, among listed positions
Reported value
$964m
combined, at the quarter end

Among the 95 comparable managers: 9 buyers (opened or added shares) and 4 sellers (trimmed or exited), at least, among listed positions. Their net change in shares is not known from listed positions, because at least one of them lists it in only one of the two quarters.

Managers listing TEVA in Q3 2025

Share of 13F value is the position’s reported value over everything the manager reported that quarter. The share change is against Q2 2025, and only where both filings list the position. A rise in value with no rise in shares is the price, not buying.

14 of 14 holders

ActionFiling
Glenview Capital Management LLC16,692,680$337m7.51%Added+868,45714 Nov 2025 (the filing on sec.gov)
Wellington Management Group LLP6,895,838$139munder 0.1%Addedn.a.14 Nov 2025 (the filing on sec.gov)
Farallon Capital Management LLC4,997,000$101m0.41%Newnew17 Feb 2026 (the filing on sec.gov)
Janus Henderson Group Ltd4,803,473$97munder 0.1%Trimmed-361,41714 Nov 2025 (the filing on sec.gov)
Maverick Capital Ltd4,300,520$87m1.16%Trimmed-77,17014 Nov 2025 (the filing on sec.gov)
Greenlight Capital3,778,777$76m3.00%Held014 Nov 2025 (the filing on sec.gov)
Viking Global Investors LP2,532,119$51m0.13%Trimmed-9,149,21414 Nov 2025 (the filing on sec.gov)
Bridgewater Associates LP864,782$17m0.07%Newnew13 Nov 2025 (the filing on sec.gov)
Steadfast Capital Management LP798,000$16m0.28%Newnew14 Nov 2025 (the filing on sec.gov)
Rokos Capital Management LLP743,929$15m0.06%Newnew14 Nov 2025 (the filing on sec.gov)
Woodline Partners LP725,086$15m0.07%Added+17614 Nov 2025 (the filing on sec.gov)
Brevan Howard Capital Management LP309,300$6.2munder 0.1%Newnew14 Nov 2025 (the filing on sec.gov)
Moore Capital Management LP165,197$3.3munder 0.1%Newnew14 Nov 2025 (the filing on sec.gov)
ARK Investment Management LLC118,721$2.4munder 0.1%Trimmed-2,15312 Nov 2025 (the filing on sec.gov)

Largest increases and reductions, by shares

Q2 2025 to Q3 2025, among managers that listed it in both quarters or opened it.

Increases

Reductions

New positions and exits

At least these many: a manager is shown exiting only where its own filing shows the position gone.

New (6)

Exited (0)

No exit shown by a manager’s own filing.

Ownership over time

Every quarter on file. A quarter-end value moves with the price as well as with the shares held; buyers and sellers count comparable managers, by shares.
22 in Q3 2024 to 14 in Q2 2026

Tracked managers listing it, at least.

01020302014201620182020202220242026
the quarter shown share split complete books; unmarked quarters rest on listed positionsClick a quarter to open it.
TEVA by quarter
QuarterHoldersReported valueBuyersSellers
Q2 201314$5.5bnn.a.n.a.
Q3 201316$5.9bnn.a.n.a.
Q4 201317$5.4bnn.a.n.a.
Q1 201424$7.7bnn.a.n.a.
Q2 201424$7.3bnn.a.n.a.
Q3 201425$7.4bnn.a.n.a.
Q4 201425$8.1bnn.a.n.a.
Q1 201525$8.7bnn.a.n.a.
Q2 201526$8.2bnn.a.n.a.
Q3 201523$8.4bnn.a.n.a.
Q4 201525$12.8bnn.a.n.a.
Q1 201627$10.3bnn.a.n.a.
Q2 201622$8.8bnn.a.n.a.
Q3 201625$7.9bnn.a.n.a.
Q4 201619$6.6bnn.a.n.a.
Q1 201722$5.9bnn.a.n.a.
Q2 201714$6.2bnn.a.n.a.
Q3 201715$3.0bnn.a.n.a.
Q4 201714$4.1bnn.a.n.a.
Q1 201813$4.8bnn.a.n.a.
Q2 201818$7.0bnn.a.n.a.
Q3 201818$6.3bnn.a.n.a.
Q4 201819$4.9bnn.a.n.a.
Q1 201914$4.7bnn.a.n.a.
Q2 201914$2.8bnn.a.n.a.
Q3 201911$2.0bnn.a.n.a.
Q4 20199$2.9bnn.a.n.a.
Q1 202014$2.0bnn.a.n.a.
Q2 202012$2.8bnn.a.n.a.
Q3 20207$2.1bnn.a.n.a.
Q4 20205$2.2bnn.a.n.a.
Q1 20218$2.6bnn.a.n.a.
Q2 20217$2.1bnn.a.n.a.
Q3 20216$1.7bnn.a.n.a.
Q4 20214$1.1bnn.a.n.a.
Q1 20229$1.4bnn.a.n.a.
Q2 202211$913mn.a.n.a.
Q3 202211$1.4bnn.a.n.a.
Q4 202211$1.7bnn.a.n.a.
Q1 20238$1.3bnn.a.n.a.
Q2 202310$184mn.a.n.a.
Q3 202313$384mn.a.n.a.
Q4 202310$373m83
Q1 202416$666m86
Q2 202422$1.8bn137
Q3 202422$2.3bn912
Q4 202418$3.0bn811
Q1 202512$2.0bn76
Q2 202511$1.8bn65
Q3 202514$964m94
Q4 202516$2.1bn1822
Q1 202614$2.0bn2019
Q2 202614$2.4bn1816

Compare with…

Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.

TEVA and LLY →TEVA and JNJ →TEVA and VRTX →Choose a stock to compare with TEVA →

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.

Which funds own TEVA, latest filings →Back to the 13F Explorer →